30
Participants
Start Date
March 15, 2025
Primary Completion Date
June 30, 2026
Study Completion Date
September 30, 2026
Saline/Placebo
NaCl(9mg/ml)
GIPR antagonist
GIP(3-30)NH2
GLP-1R antagonist
GLP-1(9-39)NH2
CCK agonist
CCK-8
RECRUITING
Rigshospitalet, Copenhagen
Rigshospitalet, Denmark
OTHER
University of Copenhagen
OTHER